Will medtech drive the next Southeastern U.S. industrial revolution?
“There is a lot more medtech talent, especially engineering talent, in the Greenville and Upstate region than most of the country realizes,” said Zylö Therapeutics CEO Scott Pancoast. “We all love being near the entrepreneurs, startups and university professors.
Our Write2Market colleague Paul Snyder recently spoke with Zylo Therapeutics CEO Scott Pancoast about the elements that make South Carolina well suited for cultivating promising ideas and companies seeking to commercialize innovations in biomedical engineering. Yesterday, our friends at MassDevice and its sister publication Medical Design & Outsourcing published the result of Paul’s interview with Scott.
“The Southeast medtech ecosystem, including the institutions of higher education, is maturing collectively. It is finding itself and demonstrating an ability to attract and retain talent thanks to a laid-back atmosphere, low cost of living and high quality of life. If you were a smart Duke graduate 20 or 30 years ago, you got hired away to New York, San Francisco or Chicago. Now the region is keeping more and more talent here.
“When combined with proximity to the Research Triangle, Clemson, Furman, support systems like the South Carolina Research Alliance and sophisticated funding organizations like Venture South, the Upstate region of South Carolina — and the Southeast as a whole — looks more and more like San Diego did about 20 years ago.”
Read more about Zylo Therapeutics’ proprietary Nanopod therapeutic delivery technology, addressable markets and next steps in the complete Medical Design & Outsourcing piece. We look forward to watching, and where possible helping, Zylo Therapuetics on its pathway to commercialization.